▶ 調査レポート

粉末止血剤の世界市場レポート2020

• 英文タイトル:Global Powder Hemostatic Agent Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。粉末止血剤の世界市場レポート2020 / Global Powder Hemostatic Agent Sales Market Report 2020 / QY20ST-06594資料のイメージです。• レポートコード:QY20ST-06594
• 出版社/出版日:QYResearch / 2020年9月25日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、131ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療機器・消耗品
• 販売価格(消費税別)
  Single User¥560,000 (USD4,000)▷ お問い合わせ
  Multi User¥840,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,120,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の粉末止血剤市場について種類別(吸収性止血剤、非吸収性止血剤)、用途別(病院、クリニック、在宅医療)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・粉末止血剤市場の概要
・世界の主要地域別粉末止血剤市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の粉末止血剤市場規模2015-2026:種類別(吸収性止血剤、非吸収性止血剤)
・世界の粉末止血剤市場規模2015-2026:用途別(病院、クリニック、在宅医療)
・粉末止血剤の北米市場規模2015-2020
・粉末止血剤のヨーロッパ市場規模2015-2020
・粉末止血剤の中国市場規模2015-2020
・粉末止血剤の日本市場規模2015-2020
・粉末止血剤の東南アジア市場規模2015-2020
・粉末止血剤のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・粉末止血剤の製造コスト分析
・販売チャネル、流通業者、顧客
・粉末止血剤の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Powder Hemostatic Agent Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Powder Hemostatic Agent market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
A powdered medicament that can stop bleeding when the body bleeds
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Powder Hemostatic Agent market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Powder Hemostatic Agent industry.
Based on our recent survey, we have several different scenarios about the Powder Hemostatic Agent YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Powder Hemostatic Agent will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Powder Hemostatic Agent market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Powder Hemostatic Agent market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Powder Hemostatic Agent market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Powder Hemostatic Agent market. The report also includes nautical information, where it shows Powder Hemostatic Agent market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Powder Hemostatic Agent market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Powder Hemostatic Agent market.
Geographical Analysis:
Based on region, the global Powder Hemostatic Agent market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Powder Hemostatic Agent market are
Johnson & Johnson(Ethicon)
Celox Medical
Amed Therapeutics
Cryolife
BioCer Entwicklungs-GmbH
Yunnan Baiyao
HHAO TECHNOLOGY

Segment by Type
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent
Segment by Application
Hospitals
Clinics
Home Care
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Powder Hemostatic Agent market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Powder Hemostatic Agent market.
• The market share of the global Powder Hemostatic Agent market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Powder Hemostatic Agent market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Powder Hemostatic Agent market.

レポート目次

1 Powder Hemostatic Agent Market Overview
1.1 Powder Hemostatic Agent Product Scope
1.2 Powder Hemostatic Agent Segment by Type
1.2.1 Global Powder Hemostatic Agent Sales by Type (2020-2026)
1.2.2 Absorbable Hemostatic Agent
1.2.3 Not Absorbable Hemostatic Agent
1.3 Powder Hemostatic Agent Segment by Application
1.3.1 Global Powder Hemostatic Agent Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Powder Hemostatic Agent Market Estimates and Forecasts (2015-2026)
1.4.1 Global Powder Hemostatic Agent Sales Growth Rate (2015-2026)
1.4.2 Global Powder Hemostatic Agent Revenue and Growth Rate (2015-2026)
1.4.3 Global Powder Hemostatic Agent Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Powder Hemostatic Agent Industry Impact
1.5.1 How the Covid-19 is Affecting the Powder Hemostatic Agent Industry
1.5.1.1 Powder Hemostatic Agent Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Powder Hemostatic Agent Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Powder Hemostatic Agent Players to Combat Covid-19 Impact

2 Powder Hemostatic Agent Estimate and Forecast by Region
2.1 Global Powder Hemostatic Agent Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Powder Hemostatic Agent Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Powder Hemostatic Agent Sales Market Share by Region (2015-2020)
2.2.2 Global Powder Hemostatic Agent Revenue Market Share by Region (2015-2020)
2.3 Global Powder Hemostatic Agent Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Powder Hemostatic Agent Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Powder Hemostatic Agent Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Powder Hemostatic Agent Estimates and Projections (2015-2026)
2.4.2 Europe Powder Hemostatic Agent Estimates and Projections (2015-2026)
2.4.3 China Powder Hemostatic Agent Estimates and Projections (2015-2026)
2.4.4 Japan Powder Hemostatic Agent Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Powder Hemostatic Agent Estimates and Projections (2015-2026)
2.4.6 India Powder Hemostatic Agent Estimates and Projections (2015-2026)
3 Global Powder Hemostatic Agent Competition Landscape by Players
3.1 Global Top Powder Hemostatic Agent Players by Sales (2015-2020)
3.2 Global Top Powder Hemostatic Agent Players by Revenue (2015-2020)
3.3 Global Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Powder Hemostatic Agent as of 2019)
3.4 Global Powder Hemostatic Agent Average Price by Company (2015-2020)
3.5 Manufacturers Powder Hemostatic Agent Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Powder Hemostatic Agent Players (Opinion Leaders)
4 Global Powder Hemostatic Agent Market Size by Type
4.1 Global Powder Hemostatic Agent Historic Market Review by Type (2015-2020)
4.1.1 Global Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
4.1.2 Global Powder Hemostatic Agent Revenue Market Share by Type (2015-2020)
4.1.3 Global Powder Hemostatic Agent Price by Type (2014-2020)
4.2 Global Powder Hemostatic Agent Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Powder Hemostatic Agent Sales Forecast by Type (2021-2026)
4.2.2 Global Powder Hemostatic Agent Revenue Forecast by Type (2021-2026)
4.2.3 Global Powder Hemostatic Agent Price Forecast by Type (2021-2026)
5 Global Powder Hemostatic Agent Market Size by Application
5.1 Global Powder Hemostatic Agent Historic Market Review by Application (2015-2020)
5.1.1 Global Powder Hemostatic Agent Sales Market Share by Application (2015-2020)
5.1.2 Global Powder Hemostatic Agent Revenue Market Share by Application (2015-2020)
5.1.3 Global Powder Hemostatic Agent Price by Application (2015-2020)
5.2 Global Powder Hemostatic Agent Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Powder Hemostatic Agent Sales Forecast by Application (2021-2026)
5.2.2 Global Powder Hemostatic Agent Revenue Forecast by Application (2021-2026)
5.2.3 Global Powder Hemostatic Agent Price Forecast by Application (2021-2026)

3 North America Powder Hemostatic Agent Market Facts & Figures
3.2 North America Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
3.3 North America Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
3.4 North America Powder Hemostatic Agent Sales Market Share by Application (2015-2020)

4 Europe Powder Hemostatic Agent Market Facts & Figures
4.2 Europe Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
4.3 Europe Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
4.4 Europe Powder Hemostatic Agent Sales Market Share by Application (2015-2020)

5 China Powder Hemostatic Agent Market Facts & Figures
5.2 China Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
5.3 China Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
5.4 China Powder Hemostatic Agent Sales Market Share by Application (2015-2020)

6 Japan Powder Hemostatic Agent Market Facts & Figures
6.2 Japan Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
6.3 Japan Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
6.4 Japan Powder Hemostatic Agent Sales Market Share by Application (2015-2020)

7 Southeast Asia Powder Hemostatic Agent Market Facts & Figures
7.2 Southeast Asia Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Powder Hemostatic Agent Sales Market Share by Application (2015-2020)

8 India Powder Hemostatic Agent Market Facts & Figures
8.2 India Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
8.3 India Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
8.4 India Powder Hemostatic Agent Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Powder Hemostatic Agent Business
12.1 Johnson & Johnson(Ethicon)
12.1.1 Johnson & Johnson(Ethicon) Powder Hemostatic Agent Corporation Information
12.1.2 Johnson & Johnson(Ethicon) Powder Hemostatic Agent Business Overview and Total Revenue
12.1.3 Johnson & Johnson(Ethicon) Powder Hemostatic Agent Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson & Johnson(Ethicon) Powder Hemostatic Agent Products Offered
12.1.5 Johnson & Johnson(Ethicon) Recent Development
12.2 Celox Medical
12.2.1 Celox Medical Powder Hemostatic Agent Corporation Information
12.2.2 Celox Medical Powder Hemostatic Agent Business Overview and Total Revenue
12.2.3 Celox Medical Powder Hemostatic Agent Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Celox Medical Powder Hemostatic Agent Products Offered
12.2.5 Celox Medical Recent Development
12.3 Amed Therapeutics
12.3.1 Amed Therapeutics Powder Hemostatic Agent Corporation Information
12.3.2 Amed Therapeutics Powder Hemostatic Agent Business Overview and Total Revenue
12.3.3 Amed Therapeutics Powder Hemostatic Agent Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Amed Therapeutics Powder Hemostatic Agent Products Offered
12.3.5 Amed Therapeutics Recent Development
12.4 Cryolife
12.4.1 Cryolife Powder Hemostatic Agent Corporation Information
12.4.2 Cryolife Powder Hemostatic Agent Business Overview and Total Revenue
12.4.3 Cryolife Powder Hemostatic Agent Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cryolife Powder Hemostatic Agent Products Offered
12.4.5 Cryolife Recent Development
12.5 BioCer Entwicklungs-GmbH
12.5.1 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Corporation Information
12.5.2 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Business Overview and Total Revenue
12.5.3 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Products Offered
12.5.5 BioCer Entwicklungs-GmbH Recent Development
12.6 Yunnan Baiyao
12.6.1 Yunnan Baiyao Powder Hemostatic Agent Corporation Information
12.6.2 Yunnan Baiyao Powder Hemostatic Agent Business Overview and Total Revenue
12.6.3 Yunnan Baiyao Powder Hemostatic Agent Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Yunnan Baiyao Powder Hemostatic Agent Products Offered
12.6.5 Yunnan Baiyao Recent Development
12.7 HHAO TECHNOLOGY
12.7.1 HHAO TECHNOLOGY Powder Hemostatic Agent Corporation Information
12.7.2 HHAO TECHNOLOGY Powder Hemostatic Agent Business Overview and Total Revenue
12.7.3 HHAO TECHNOLOGY Powder Hemostatic Agent Sales, Revenue and Gross Margin (2015-2020)
12.7.4 HHAO TECHNOLOGY Powder Hemostatic Agent Products Offered
12.7.5 HHAO TECHNOLOGY Recent Development

13 Powder Hemostatic Agent Manufacturing Cost Analysis
13.1 Powder Hemostatic Agent Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Powder Hemostatic Agent
13.4 Powder Hemostatic Agent Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Powder Hemostatic Agent Distributors List
14.3 Powder Hemostatic Agent Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Powder Hemostatic Agent Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Powder Hemostatic Agent Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Powder Hemostatic Agent Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Powder Hemostatic Agent Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Powder Hemostatic Agent Players to Combat Covid-19 Impact
Table 8. Global Market Powder Hemostatic Agent Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Powder Hemostatic Agent Sales (K Units) by Region (2015-2020)
Table 10. Global Powder Hemostatic Agent Sales Market Share by Region (2015-2020)
Table 11. Global Powder Hemostatic Agent Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Powder Hemostatic Agent Revenue Share by Region (2015-2020)
Table 13. Global Powder Hemostatic Agent Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Powder Hemostatic Agent Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Powder Hemostatic Agent Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Powder Hemostatic Agent Revenue Share Forecast by Region (2021-2026)
Table 17. Global Powder Hemostatic Agent (K Units) of Key Companies (2015-2020)
Table 18. Global Powder Hemostatic Agent Sales Share by Company (2015-2020)
Table 19. Global Powder Hemostatic Agent Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Powder Hemostatic Agent Revenue Share by Company (2015-2020)
Table 21. Global Powder Hemostatic Agent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Powder Hemostatic Agent as of 2019)
Table 22. Global Powder Hemostatic Agent Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Powder Hemostatic Agent Manufacturing Sites and Area Served
Table 24. Manufacturers Powder Hemostatic Agent Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Powder Hemostatic Agent Players
Table 27. Global Powder Hemostatic Agent Sales (K Units) by Type (2015-2020)
Table 28. Global Powder Hemostatic Agent Sales Share by Type (2015-2020)
Table 29. Global Powder Hemostatic Agent Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Powder Hemostatic Agent Price (K Units) by Type (2015-2020)
Table 31. Global Powder Hemostatic Agent Sales Share by Type (2021-2026)
Table 32. Global Powder Hemostatic Agent Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Powder Hemostatic Agent Revenue Share by Type (2021-2026)
Table 34. Global Powder Hemostatic Agent Price (K Units) by Type (2021-2026)
Table 35. Global Powder Hemostatic Agent Sales (K Units) by Application (2015-2020)
Table 36. Global Powder Hemostatic Agent Sales Share by Application (2015-2020)
Table 37. Global Powder Hemostatic Agent Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Powder Hemostatic Agent Price (K Units) by Application (2015-2020)
Table 39. Global Powder Hemostatic Agent Sales (K Units) by Application (2021-2026)
Table 40. Global Powder Hemostatic Agent Sales Share by Application (2021-2026)
Table 41. Global Powder Hemostatic Agent Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Powder Hemostatic Agent Revenue Share by Application (2021-2026)
Table 43. Global Powder Hemostatic Agent Price (K Units) by Application (2021-2026)
Table 44. United States Powder Hemostatic Agent Sales (K Units) by Company (2015-2020)
Table 45. United States Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
Table 46. United States Powder Hemostatic Agent Sales (K Units) by Type (2015-2020)
Table 47. United States Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
Table 48. United States Powder Hemostatic Agent Sales (K Units) by Application (2015-2020)
Table 49. United States Powder Hemostatic Agent Sales Market Share by Application (2015-2020)
Table 50. Europe Powder Hemostatic Agent Sales (K Units) by Company (2015-2020)
Table 51. Europe Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
Table 52. Europe Powder Hemostatic Agent Sales (K Units) by Type (2015-2020)
Table 53. Europe Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
Table 54. Europe Powder Hemostatic Agent Sales (K Units) by Application (2015-2020)
Table 55. Europe Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
Table 56. China Powder Hemostatic Agent Sales (K Units) by Company (2015-2020)
Table 57. China Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
Table 58. China Powder Hemostatic Agent Sales (K Units) by Type (2015-2020)
Table 59. China Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
Table 60. China Powder Hemostatic Agent Sales (K Units) by Application (2015-2020)
Table 61. China Powder Hemostatic Agent Sales Market Share by Application (2015-2020)
Table 62. Japan Powder Hemostatic Agent Sales (K Units) by Company (2015-2020)
Table 63. Japan Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
Table 64. Japan Powder Hemostatic Agent Sales (K Units) by Type (2015-2020)
Table 65. Japan Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
Table 66. Japan Powder Hemostatic Agent Sales (K Units) by Application (2015-2020)
Table 67. Japan Powder Hemostatic Agent Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Powder Hemostatic Agent Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Powder Hemostatic Agent Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Powder Hemostatic Agent Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Powder Hemostatic Agent Sales Market Share by Application (2015-2020)
Table 74. India Powder Hemostatic Agent Sales (K Units) by Company (2015-2020)
Table 75. India Powder Hemostatic Agent Sales Market Share by Company (2015-2020)
Table 76. India Powder Hemostatic Agent Sales (K Units) by Type (2015-2020)
Table 77. India Powder Hemostatic Agent Sales Market Share by Type (2015-2020)
Table 78. India Powder Hemostatic Agent Sales (K Units) by Application (2015-2020)
Table 79. India Powder Hemostatic Agent Sales Market Share by Application (2015-2020)
Table 80. Johnson & Johnson(Ethicon) Corporation Information
Table 81. Johnson & Johnson(Ethicon) Description and Business Overview
Table 82. Johnson & Johnson(Ethicon) Powder Hemostatic Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson(Ethicon) Powder Hemostatic Agent Product
Table 84. Johnson & Johnson(Ethicon) Recent Development
Table 85. Celox Medical Corporation Information
Table 86. Celox Medical Description and Business Overview
Table 87. Celox Medical Powder Hemostatic Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Celox Medical Powder Hemostatic Agent Product
Table 89. Celox Medical Recent Development
Table 90. Amed Therapeutics Corporation Information
Table 91. Amed Therapeutics Description and Business Overview
Table 92. Amed Therapeutics Powder Hemostatic Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Amed Therapeutics Powder Hemostatic Agent Product
Table 94. Amed Therapeutics Recent Development
Table 95. Cryolife Corporation Information
Table 96. Cryolife Description and Business Overview
Table 97. Cryolife Powder Hemostatic Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cryolife Powder Hemostatic Agent Product
Table 99. Cryolife Recent Development
Table 100. BioCer Entwicklungs-GmbH Corporation Information
Table 101. BioCer Entwicklungs-GmbH Description and Business Overview
Table 102. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product
Table 104. BioCer Entwicklungs-GmbH Recent Development
Table 105. Yunnan Baiyao Corporation Information
Table 106. Yunnan Baiyao Description and Business Overview
Table 107. Yunnan Baiyao Powder Hemostatic Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Yunnan Baiyao Powder Hemostatic Agent Product
Table 109. Yunnan Baiyao Recent Development
Table . HHAO TECHNOLOGY Corporation Information
Table . HHAO TECHNOLOGY Description and Business Overview
Table . HHAO TECHNOLOGY Powder Hemostatic Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . HHAO TECHNOLOGY Powder Hemostatic Agent Product
Table . HHAO TECHNOLOGY Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Powder Hemostatic Agent Distributors List
Table 118. Powder Hemostatic Agent Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Powder Hemostatic Agent Product Picture
Figure 2. Global Powder Hemostatic Agent Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Powder Hemostatic Agent Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Home Care Examples
Figure 9. Global Powder Hemostatic Agent Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Powder Hemostatic Agent Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Powder Hemostatic Agent Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Powder Hemostatic Agent Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Powder Hemostatic Agent Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Powder Hemostatic Agent Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Powder Hemostatic Agent Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Powder Hemostatic Agent Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Powder Hemostatic Agent Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Powder Hemostatic Agent Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Powder Hemostatic Agent Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Powder Hemostatic Agent Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Powder Hemostatic Agent Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Powder Hemostatic Agent Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Powder Hemostatic Agent Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Powder Hemostatic Agent Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Powder Hemostatic Agent Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Powder Hemostatic Agent Players Market Share by Revenue in Powder Hemostatic Agent 2015 & 2019
Figure 27. Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Powder Hemostatic Agent Revenue Share by Type (2015-2020)
Figure 29. Global Powder Hemostatic Agent Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Powder Hemostatic Agent Revenue Share by Application (2015-2020)
Figure 31. Global Powder Hemostatic Agent Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Powder Hemostatic Agent Sales Market Share by Type in 2019
Figure 33. United States Powder Hemostatic Agent Sales Market Share by Type in 2019
Figure 34. Europe Powder Hemostatic Agent Sales Market Share by Company in 2019
Figure 35. Europe Powder Hemostatic Agent Sales Market Share by Type in 2019
Figure 36. Europe Powder Hemostatic Agent Sales Market Share by Application in 2019
Figure 37. China Powder Hemostatic Agent Sales Market Share by Company in 2019
Figure 38. China Powder Hemostatic Agent Sales Market Share by Type in 2019
Figure 39. China Powder Hemostatic Agent Sales Market Share by Application in 2019
Figure 40. Japan Powder Hemostatic Agent Sales Market Share by Company in 2019
Figure 41. Japan Powder Hemostatic Agent Sales Market Share by Type in 2019
Figure 42. Japan Powder Hemostatic Agent Sales Market Share by Application in 2019
Figure 43. Southeast Asia Powder Hemostatic Agent Sales Market Share by Company in 2019
Figure 44. Southeast Asia Powder Hemostatic Agent Sales Market Share by Type in 2019
Figure 45. Southeast Asia Powder Hemostatic Agent Sales Market Share by Application in 2019
Figure 46. India Powder Hemostatic Agent Sales Market Share by Company in 2019
Figure 47. India Powder Hemostatic Agent Sales Market Share by Type in 2019
Figure 48. India Powder Hemostatic Agent Sales Market Share by Application in 2019
Figure 49. Johnson & Johnson(Ethicon) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Celox Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Amed Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Cryolife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. BioCer Entwicklungs-GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Yunnan Baiyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. HHAO TECHNOLOGY Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Powder Hemostatic Agent
Figure 58. Manufacturing Process Analysis of Powder Hemostatic Agent
Figure 59. Powder Hemostatic Agent Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed